CHHHF (CareRx) Change In Receivables : $5.2 Mil (TTM As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is CareRx Change In Receivables?

CareRx's change in receivables for the quarter that ended in Sep. 2024 was $2.4 Mil. It means CareRx's Accounts Receivable declined by $2.4 Mil from Jun. 2024 to Sep. 2024 .

CareRx's change in receivables for the fiscal year that ended in Dec. 2023 was $1.1 Mil. It means CareRx's Accounts Receivable declined by $1.1 Mil from Dec. 2022 to Dec. 2023 .

CareRx's Accounts Receivable for the quarter that ended in Sep. 2024 was $21.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CareRx's Days Sales Outstanding for the three months ended in Sep. 2024 was 28.72.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CareRx's liquidation value for the three months ended in Sep. 2024 was $-73.9 Mil.

CareRx Change In Receivables Historical Data

The historical data trend for CareRx's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareRx Change In Receivables Chart

CareRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.78

1.87

-8.38

0.91

1.09

CareRx Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															0.78	0.14	3.33	-0.60	2.36

CareRx Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.2 Mil.

CareRx (OTCPK:CHHHF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CareRx's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	21.573	/	68.534	*	91
=	28.72

2. In Ben Graham's calculation of liquidation value, CareRx's accounts receivable are only considered to be worth 75% of book value:

CareRx's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6.235	-	102.957	+	0.75 * 21.573	+	0.5 * 13.272
=	-73.9

CareRx Change In Receivables Related Terms

Thank you for viewing the detailed overview of CareRx's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CareRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareRx Corp (OTCPK:CHHHF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CRRX:Canada

Address

320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6

Website

https://www.carerx.ca

CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education, and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.